parC Mutation Conferring Ciprofloxacin Resistance in Streptococcus pyogenes BM4513
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (11) , 3686-3687
- https://doi.org/10.1128/aac.46.11.3686-3687.2002
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In Vitro Activities of Novel Des-Fluoro(6) Quinolone BMS-284756 against Mutants of Streptococcus pneumoniae , Streptococcus pyogenes , and Staphylococcus aureus Selected with Different QuinolonesAntimicrobial Agents and Chemotherapy, 2002
- Selection of Streptococcus pneumoniae Mutants Having Reduced Susceptibility to Moxifloxacin and LevofloxacinAntimicrobial Agents and Chemotherapy, 2002
- Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae : Contributions of Type II Topoisomerase Mutations and Efflux to Levels of ResistanceAntimicrobial Agents and Chemotherapy, 2000
- Resistance to Multiple Fluoroquinolones in a Clinical Isolate of Streptococcus pyogenes : Identification of gyrA and parC and Specification of Point Mutations Associated with ResistanceAntimicrobial Agents and Chemotherapy, 2000
- Pathogenesis of Group A Streptococcal InfectionsClinical Microbiology Reviews, 2000
- Pathogenesis of Group A Streptococcal InfectionsClinical Microbiology Reviews, 2000
- Group A streptococci in the 1990sJournal of Antimicrobial Chemotherapy, 2000
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999